Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Carcinogenicity

Currently viewing:

Administrative data

Description of key information

Two inhalation studies in rats and mice are available. Both studies are reliable without restrictions as they were conducted under GLP and according to OECD guideline 453. 

Key value for chemical safety assessment

Carcinogenicity: via inhalation route

Endpoint conclusion
Dose descriptor:
NOAEC
11 058 mg/m³

Justification for classification or non-classification

No carcinogenic effect as evidenced by any increase in tumor incidence occurred from exposure to PGME at any concentration in either species.

Additional information

Repeated exposure to dipropylene glycol methyl ether acetate resulted in toxicity generally only at high exposure levels and usually consisted of increased organ weights without accompanying histopathology. In vitro genotoxicty studies are negative, indicating that dipropylene glycol methyl ether acetate is not genotoxic. No carcinogenicity studies are available for DPMA.The sole propylene glycol ether that has been subjected to chronic toxicity/carcinogenicity testing is propylene glycol methyl ether (PGME). Thus, the PGME study is used as a surrogate for dipropylene glycol methyl ether acetate. PGME, tested by inhalation in rats at concentrations up to 3,000 ppm, caused very little chronic toxicity and caused no cancer.